| 1 |
Thygesen K,Mair J,Mueller C, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study group on biomarkers in cardiology of the ESC working group on acute cardiac care[J]. Eur Heart J, 2012, 33(16): 2001-2006.
|
| 2 |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2)：98-122.
|
| 3 |
Yancy CW,Jessup M,Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation, 2013, 128(16): e240-e327.
|
| 4 |
Fermann GJ,Lindsell CJ,Storrow AB, et al. Galectin 3 complements BNP in risk stratification in acute heart failure[J]. Biomarkers, 2012, 17(8): 706-713.
|
| 5 |
Tomaschitz A,Ritz E,Pieske B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease[J]. Cardiovasc Res, 2012, 94(1): 10-19.
|
| 6 |
Wannamethee SG,Welsh P,Papacosta O, et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease[J]. Circ Heart Fail, 2014, 7(5): 732-739.
|
| 7 |
Gruson D,Lepoutre T,Ahn SA, et al. Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure[J]. Clin Biochem, 2013, 46(4-5): 391-394.
|
| 8 |
Bansal N,Zelnick L,Robinson-Cohen C, et al. Serum parathyroid hormone and 25-hydroxyvitamin D concen trations and risk of incident heart failure: the multi-ethnic study of atherosclerosis[J]. J Am Heart Assoc, 2014, 3(6): e001278.
|
| 9 |
张萍,娄美娜,章慧娣. 心率减速力对慢性心力衰竭患者近期预后的评估价值[J/CD]. 中华危重症医学杂志：电子版, 2015, 8(1)：12-16.
|
| 10 |
唐关敏,汪世军,胡惠林, 等. 中老年慢性心力衰竭患者血浆Apelin表达变化及RAS阻滞剂的调控作用[J/CD]. 中华危重症医学杂志：电子版, 2014, 7(1)：35-40.
|
| 11 |
胡道卿,刘宇. 甲状旁腺激素对心力衰竭预警作用研究进展[J]. 现代医药卫生, 2014, 30(2)：219-221.
|
| 12 |
Gruson D,Ahn SA,Rousseau MF. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure[J]. Peptides, 2015(64): 24-28.
|
| 13 |
Cavalier E,Delanaye P,Lukas P, et al. Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations[J]. Clin Chem Lab Med, 2014, 52(8): 1137-1141.
|
| 14 |
Altay H,Colkesen Y. Parathyroid hormone and heart failure: novel biomarker strategy[J]. Endocr Metab Immune Disord Drug Targets, 2013, 13(1): 100-104.
|
| 15 |
Bernheim J,Benchetrit S. The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases[J]. Nephrol Dial Transplant, 2011, 26(8): 2433-2438.
|
| 16 |
Parker BD,Schurgers LJ,Brandenburg VM, et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the heart and soul study[J]. Ann Intern Med, 2010, 152(10): 640-648.
|
| 17 |
Wu G,Wang X,Wang X, et al. Serum parathyroid hormone levels predict discharge and readmission for heart failure[J]. Genet Test Mol Biomarkers, 2016, 20(6): 328-334.
|
| 18 |
吴刚勇,宗刚军,陈景开, 等. 血清甲状旁腺激素水平预测心力衰竭患者住院治疗的初步探讨[J]. 中华医学杂志, 2013, 93(28)：2205-2208.
|
| 19 |
陈英,刘凯,符生苗, 等. 血清甲状旁腺激素水平测定在老年心力衰竭严重度评估中的应用[J]. 临床输血与检验, 2014, 16(4)：343-346.
|
| 20 |
Altay H,Zorlu A,Kocum HT, et al. Relationship between parathyroid hormone and depression in heart failure[J]. Arq Bras Cardiol, 2012, 99(4): 915-923.
|
| 21 |
Loncar G,Bozic B,Dimkovic S, et al. Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure[J]. J Endocrinol Invest, 2011, 34(3): e78-e85.
|